NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹1,343 Cr | ₹995 Cr | ₹752 Cr | ₹465 Cr | ₹308 Cr |
What is the latest Profit & Loss Account Balance ratio of NEULAND LABORATORIES ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2026 | ₹1,343 Cr |
| Mar2025 | ₹995 Cr |
| Mar2024 | ₹752 Cr |
| Mar2023 | ₹465 Cr |
| Mar2022 | ₹308 Cr |
How is Profit & Loss Account Balance of NEULAND LABORATORIES Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,343 Cr | 35.05 | |
| Mar2025 | ₹995 Cr | 32.18 | |
| Mar2024 | ₹752 Cr | 61.74 | |
| Mar2023 | ₹465 Cr | 50.99 | |
| Mar2022 | ₹308 Cr | - | |
Compare Profit & Loss Account Balance of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹28,996.0 Cr | -2.6% | -4.3% | 52.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -1.5% | 15.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,223.0 Cr | -3% | 8.3% | 52.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹183,453.0 Cr | -2.2% | -1.5% | 35% | Stock Analytics | |
| CIPLA | ₹109,849.0 Cr | -0.6% | -4.9% | -13% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,591.8 Cr | 0.2% | -3.9% | -11.8% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -2.6% |
-4.3% |
52.3% |
| SENSEX | -1.6% |
-4.7% |
-8.3% |
You may also like the below Video Courses